Bunyamwera virus, an emerging pathogen of veterinary importance in Argentina  by Tauro, L.B. et al.
10th IEIDC Abstracts / Journal of Equine Veterinary Science 39 (2016) S26eS32 S27understanding of its pathogenesis beyond the essential role of
viremia is rudimentary. To address questions regarding viral and
host factors for the pathogenesis of EHM, the focus of this study
was to compare viruses with differing neuropathogenic potential.
Four experimental groups of horses were established and
included uninfected controls, wild type infected horses (Ab4),
polymerase mutant infected horses (Ab4 N752) and gD mutant
infected horses (EHV-1 gD4). Animals were assessed for 21 days
post infection (p.i.). Blood and nasal swabs were assessed for
viremia and nasal shedding by real time PCR. Nasal secretions and
cerebrospinal ﬂuid (CSF) were collected for cytokine measure-
ment and serum neutralization (SN) titers were determined at
regular intervals. All horses were euthanized 10 weeks p.i. and
tissues were collected for histology. Ab4 N752 infected horses
showed the most severe respiratory disease followed by Ab4
infected horses. EHV-1 gD4 infected horses showed only mild
respiratory disease. Three Ab4 infected horses developed signs of
EHM but no horses in the other groups showed neurological
signs. Furthermore, only Ab4 infected horses presented a classical
bi-phasic fever. Ab4 N752 infected horses showed only primary
fevers and EHV-1 gD4 infected horses showed only late secondary
fevers. Nasal shedding and viremia differed signiﬁcantly between
infection groups, while EHV-1 SN increased in all groups p.i. to
comparable levels. IFN-gammawas reduced and IL-10 production
was completely inhibited in the CSF after Ab4 infection, but no
signiﬁcant changes were observed in any of the other groups. In
contrast to CSF, IFN-gamma was signiﬁcantly increased in nasal
secretions of Ab4 infected horses. IFN-alpha was not detectable in
nasal secretions before infection, but was signiﬁcantly induced
following infection in all infection groups. Finally, horses in the
AB4 infected group showed signiﬁcant signs of inﬂammation and
degeneration in the spinal cord, brain and testis upon histological
examination, while inﬂammation was much milder or absent in
horses of the other infection groups. In conclusion, we detect
differences in respiratory and neurological disease as well as nasal
shedding and viremia of horses infected with Ab4 and EHV-1
mutant viruses of differing neuropathogenic potential. These
differences appear to be associated with a differing ability of WT
and mutant viruses to infect immune privileged sites and
modulate host responses and induction of interferons and IL-10.
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Acquired equine polyneuropathy (AEP) is an emerging disease of
horses in northern Europe since the 1990’s [1,2]. Today it is the
most prevalent peripheral nerve disease in equids in Scandinavia.
Affected horses show knuckling of the fetlock joints due to
dysfunction of metatarsophalangeal extensor muscles, mostly in
the pelvic limbs. In severe cases, paraplegia leads to euthanasia,
with loss of about one third of the cases. Surviving cases normally
recover after a long convalescence. The pathologic features are
unique to the syndrome, with a large ﬁbre neuropathy of pe-
ripheral nerves and pathology of the myelin-building Schwann
cells. The disease is still an enigma despite scientists’ attention
and many efforts to ﬁnd its etiology. This presentation aims to
discuss factors of importance to build a hypothesis for the etiol-
ogy for AEP. Speaking for an infectious or toxico-infectious eti-
ology is the typical course of the disease with several genetically
unrelated cases appearing in one premises during a limited timeperiod, and there are signs of spatio-temporal clusterings of
outbreaks [3]. Often the outbreaks start at winter time, when
horses are stabled in close contact. Also, some inﬂammatory
changes are apparent in the nerves. On the other hand, if affected
horses are moved, they do not transmit disease to new animals,
which means that direct and indirect contact is not enough to
transmit disease. Also, the horses do not display neither fever nor
changes in their leukogram or inﬂammatory markers in blood.
They are often seronegative for EHV-1, Borrelia and granulocytic
anaplasma. A similar inﬂammatory nerve disease in humans is
Guillain-Barre syndrome (GBS), also with unknown etiology.
However, there is evidence that GBS in humans may be an im-
mune-mediated sequel within 6 weeks after a gastrointestinal or
respiratory infection like Campylobacter jejuni, Epstein-Barr vi-
rus, Mycoplasma pneumoniae and cytomegalovirus [4]. Some-
times vaccinations are also suggested to cause GBS. Which
subclinical or clinical infections in a horse might be candidates for
an autoimmune reaction to nerves? The main theory for AEP
today is that wrapped forage has a part in the riddle. Could a
forage-borne microbe or microbial toxin be the culprit? In
conclusion, we need to work with open minds on this riddle at
this point, and merge knowledge from various areas.Acknowledgments
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In Argentina the viruses with veterinary importance belong
mainly to the genus Alphavirus (Eastern Equine Encephalitis vi-
rus, Western Equine Encephalitis virus) and Flavivirus (West Nile
virus); the ﬁrst showed high impact until the late 80s while the
second became important after the twenty-ﬁrst century.
Currently the Bunyamwera virus (BUNV) included within the
Orthobunyavirus genus has emerged in our country as a
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abortions in horses. BUNV includes 27 strains / isolates with ac-
tivity around the world. In the US, Panama, Colombia and Guyana
it is documented the pathogenic potential of BUNV in both ani-
mals and humans because the infection by this virus was found
associated with the production of Central Nervous System dis-
ease, congenital malformations and abortions. In Argentina, two
strains of BUNV have been recovered frommosquitoes, (1) CbaAr-
426 (Cordoba, 1964/1965), and (2) AG83-1746 (Santa Fe, 1981).
Serological surveys have detected high prevalence of BUNV
infection in humans (healthy and undifferentiated febrile syn-
drome and neurological) as well as in domestic and wild life
animals but only febrile diseases have been reported in humans
infected by BUNV. During the autumn of 2013 in of Santa Fe
province, took place the ﬁrst outbreak by BUNV in the country,
during which occurred the death of two horses with neurological
syndrome from which 2 new strains of BUNV (SFCrEq231 and
SFBzEq232) were isolated; later (July, 2013) in the same area
another BUNV strain (SFAbCrEq238) was recovered from the
brain of an equine abortion. Serologic records in cohabiting
horses in Santa Fe province indicate a seroprevalence over 50%
(strain CbaAr-426). Genomic ampliﬁcation and the subsequent
phylogenetic analysis of a 250 bp of segment S the 3 new strains
showed 100% homology between them and 98,9% with the strain
CbaAr426 isolated in Cordoba which although is responsible for
high seroprevalence in domestic and wild life animals has not
been found associated with disease production. Moreover the
phylogenetic analysis of the complete genome of the new strains
with the other strains of BUNV available in Genbank showed a
homology of 99,4 % with strain 86MSP18 (isolated from a human
with febrile syndrome in Panama in 1985) for the Segment S. For
this ﬁnal phylogenetic analysis, the strain CbaAr426 It was not
included because the whole genome sequence is not available.
These ﬁndings highlight the circulation of new strains of BUNV in
Argentina and constitute the ﬁrst evidence of a possible associa-
tion between infection by BUNV and neurological syndrome in
domestic animals for our country. Moreover, these results un-
derline the importance of intensifying the surveillance of BUNV to
determine its likely real impact and to improve differential
diagnosis.
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Equine Protozoal Myeloencephalitis (EPM) is a serious neurologic
disease in equids. Although seroprevalence has been reported to
be high in horses, the actual prevalence of disease has been
estimated between 0.5 to 1%, based on laboratory submission to
the University of Kentucky. However, incidence (number of new
diagnosed cases) of EPM in horses has not been reported. The
purpose of this studywas to determine the incidence and breed of
EPM cases in equids presented to Veterinary Teaching Hospitals
(VTH) in North America and to determine if the incidence of EPM
was decreasing over time. A secondary purpose of the study was
to survey veterinary practitioners to determine if they perceive
that the incidence of EPM is decreasing over time. Equine acces-
sions reported to the Veterinary Medical Data Base (VMDB) from
1990-2014 were used for this study. Medical records from theVMDB (Systematized Nomenclature of Medicine [SNOMED] and
Systematized Nomenclature of Veterinary Diseases and Opera-
tions [SNVDO]) were accessed for overall EPM proportional
morbidity rates (PMR), PMR by database, PMR compared by
breed, and annual PMR from 1990-2014. Also, results of an on-line
survey questionnaire (Zoomerang.com) were summarized. The
on-line survey, containing 12 questions, was completed by equine
practitioners who were members of either the Equine Clinicians
Network (ECN) or the American Association of Equine Practi-
tioners (AAEP) list-serves. There were 2,748 cases of EPM per
312,222 accessions resulting in an overall PMR of 0.88%, among
hospitals reporting to the VMDB during the study period. The
PMR was not signiﬁcantly different between the two databases
(SNOMED and SNOVDO). Proportional diagnoses increased from
0.293% in 1990 to 1.952% in 1997, which was a signiﬁcantly
(P<0.05) higher than the overall PMR (0.88%). Although, there
was a signiﬁcant increase in the PMR of EPM cases from 1995-
1998, there was no evidence of a signiﬁcant temporal increase
over the 24-year study period. The PMRs were signiﬁcantly
(P<0.05) higher in Standardbreds (1.592%), Walking Horses
(1.367%), Thoroughbreds (1.314%), andWarmbloods (1.096%) than
all breeds combined (0.88%). However, the PMRs were signiﬁ-
cantly (P<0.05) lower in Draft breeds (0.518%), Ponies (0.591%),
and Quarter Horses (0.694%), when compared to the PMR for all
breeds. For the survey, there were 221 respondents and 153 (69%)
were from private practice and 68 (31%) were from academia. The
average number of practitioners per practice was 8. Thirty-eight
percent of the equine practitioners perceived that it had not
changed over the previous 2-4 years. Our ﬁndings seem to sug-
gest breed predispositions, with higher PMRs being observed in
Standardbreds, Walking Horses, and Thoroughbreds and lower
PMRs being observed in Draft breeds, ponies and Quarter Horses.
The majority of practitioners surveyed thought that the incidence
of EPM had either not changed or decreased in the previous 2-4
years. Although there was a signiﬁcant increase in EPM case
diagnosed from 1995-1997, it appears from these data that the
overall proportion of EPM cases has essentially not changed over
the past 24 years.
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Latent infections are the cornerstone of EHV-1’s continued suc-
cess. Consequently, EHV-1, unlike equine inﬂuenza and even
strangles (S. equi) is not an infection that can be practically
eradicated from equine populations. Conﬁrmation and contain-
ment of EHV-1 outbreaks is necessary to avoid spread of infection
and to minimise the potential for signiﬁcant impact to the equine
industry frommorewidespread outbreaks, in particular, large and
widely disseminated outbreaks of EHV-1 neurological disease. In
recent years, experience gained through management of EHV-1
neurological disease outbreaks in the United Kingdom (UK) has
led to establishment of protocols to control the spread of disease
and minimise equine industry losses. To that end the Animal
Health Trust, working with the UK equine industry, has proposed
three possible tiers of approach as to how EHV-1 neurological
outbreaks can be practically managed. The three tiers of approach
are referred to as Gold, Silver and Bronze and whilst they are all
based on the same set of principles of Segregation of the popula-
tion, Collection and Testing of samples and Observation of clinical
